| pubmed-article:10235427 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0035173 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0149871 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0003440 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0019134 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0040018 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0443199 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C1149593 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0254657 | lld:lifeskim |
| pubmed-article:10235427 | lifeskim:mentions | umls-concept:C0380191 | lld:lifeskim |
| pubmed-article:10235427 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10235427 | pubmed:dateCreated | 1999-8-4 | lld:pubmed |
| pubmed-article:10235427 | pubmed:abstractText | Direct thrombin inhibitors belong to a new class of antithrombotic drugs whose effects on blood coagulation in vivo in patients suffering from acute thrombotic conditions have not yet been fully explored. | lld:pubmed |
| pubmed-article:10235427 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10235427 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235427 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10235427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10235427 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10235427 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10235427 | pubmed:issn | 0340-6245 | lld:pubmed |
| pubmed-article:10235427 | pubmed:author | pubmed-author:ReberGG | lld:pubmed |
| pubmed-article:10235427 | pubmed:author | pubmed-author:RascheHH | lld:pubmed |
| pubmed-article:10235427 | pubmed:author | pubmed-author:TschoppT BTB | lld:pubmed |
| pubmed-article:10235427 | pubmed:author | pubmed-author:HultingJJ | lld:pubmed |
| pubmed-article:10235427 | pubmed:author | pubmed-author:BounameauxHH | lld:pubmed |
| pubmed-article:10235427 | pubmed:author | pubmed-author:EhringerHH | lld:pubmed |
| pubmed-article:10235427 | pubmed:author | pubmed-author:RapoldH JHJ | lld:pubmed |
| pubmed-article:10235427 | pubmed:author | pubmed-author:GastAA | lld:pubmed |
| pubmed-article:10235427 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10235427 | pubmed:volume | 81 | lld:pubmed |
| pubmed-article:10235427 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10235427 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10235427 | pubmed:pagination | 498-501 | lld:pubmed |
| pubmed-article:10235427 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:meshHeading | pubmed-meshheading:10235427... | lld:pubmed |
| pubmed-article:10235427 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10235427 | pubmed:articleTitle | Differential inhibition of thrombin activity and thrombin generation by a synthetic direct thrombin inhibitor (napsagatran, Ro 46-6240) and unfractionated heparin in patients with deep vein thrombosis. ADVENT Investigators. | lld:pubmed |
| pubmed-article:10235427 | pubmed:affiliation | Division of Angiology and Hemostasis, University Hospital of Geneva, Switzerland. bounamea@cmu.unige.ch | lld:pubmed |
| pubmed-article:10235427 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10235427 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10235427 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10235427 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10235427 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10235427 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10235427 | lld:pubmed |
